2013•Neurourology and UrodynamicsRequires access

Combination treatment with mirabegron and solifenacin in patients with overactive bladder (OAB) - efficacy and safety results from a randomised phase II study (Symphony)

Paul Abrams, Con Kelleher, David Staskin, Richard Kay, Reynaldo Martina, Donald Newgreen, Asha Paireddy, Rob van Maanen, Arwin Ridder

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Mirabegron, Solifenacin, Overactive bladder, Medicine, Symphony, Urology, Nocturia, Safety profile

Back to paper search Browse research topics Original source

Combination treatment with mirabegron and solifenacin in patients with overactive bladder (OAB) - efficacy and safety results from a randomised phase II study (Symphony) — Research Paper | ScholarLens